Harrow, Inc. (HROW): A Bull Case Theory
We came across a bullish thesis on Harrow, Inc. (HROW) on Simon’s Substack by Simon. In this article, we will summarize the bulls’ thesis on HROW.
Harrow Inc. (HROW)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.97 | 20,000 | Large Shareholder | 3,815,000 | 2024-04-25 | Filing | |
| $10.15 | 8,285 | Large Shareholder | 3,795,000 | 2024-04-24 | Filing | |
| $10.29 | 11,715 | Large Shareholder | 3,786,715 | 2024-04-23 | Filing | |
| $10.56 | 29,400 | Large Shareholder | 3,775,000 | 2024-04-19 | Filing | |
| $12.82 | 50,000 | Large Shareholder | 3,745,600 | 2024-03-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.62 | 40,000 | Director | 26,100 | 2022-09-30 | Filing | |
| $10.04 | 3,900 | Director | 66,100 | 2021-09-24 | Filing | |
| $9.02 | 5,840 | Director | 70,000 | 2021-09-16 | Filing | |
| $9.09 | 14,160 | Director | 75,840 | 2021-09-15 | Filing | |
| $10.75 | 10,000 | Director | 90,000 | 2021-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% |
News See All
Harrow Health, Inc. (NASDAQ:HROW) Q2 2024 Earnings Call Transcript
Operator: Good morning and welcome to the Harrow Second Quarter 2024 Earnings Conference Call. My name is Josh and I will be your operator for today's call.
Harrow Health, Inc. (NASDAQ:HROW) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Harrow, Inc. First Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript
Operator: Good morning and welcome to Harrow's Fourth Quarter and Year-End 2023 Earnings Conference Call. My name is Drew, and I will be your operator for today's call.
Harrow (HROW) Fell on Lowering the Guidance
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Value Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
11 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the 11 best small cap pharma stocks to invest in.
Here’s How Harrow (HROW) Weighed on SRK Capital’s Performance
SRK Capital, an investment management firm, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Harrow Health, Inc. (NASDAQ:HROW) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Harrow's Third Quarter 2023 Earnings Conference Call. My name is Betsy, and I will be your operator for today's call.
Harrow Health, Inc. (NASDAQ:HROW) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Harrow's Second Quarter 2023 Earnings Conference Call. My name is Kate, and I will be your operator for today's call.
10 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the ten best small cap pharma stocks to buy.
Billionaire Hedge Funds
